| Literature DB >> 35124582 |
Hai-Bing Xu1, An-Ding Dong1, Mu-Tai Liu2, Hsien-Chun Tseng3,4, Chien-Yi Chen3,5,1, Sung-Yi Tsai1,1.
Abstract
BACKGROUND: According to statistics of the Ministry of Health and Welfare in 2017, the second leading cause of death in Taiwan was lung cancer.Entities:
Keywords: Photoneutron dose equivalent; lung cancer; phantom; risk assessment; thermoluminescence dosimeter
Mesh:
Substances:
Year: 2022 PMID: 35124582 PMCID: PMC9028617 DOI: 10.3233/THC-228004
Source DB: PubMed Journal: Technol Health Care ISSN: 0928-7329 Impact factor: 1.205
Rando, polymethylmethacrylate (PMMA) phantoms’ dimension and physical properties
| Phantom | Rando | Polymethylmethacrylate (PMMA) | ||||
|---|---|---|---|---|---|---|
| Weight (kg) | 70 | 10 | 30 | 50 | 70 | 90 |
| Height (cm) | 94.5 | 50 | 78 | 84 | 93 | 112 |
| Weight (kg) | 34.5 | 6.75 | 19.0 | 31.5 | 44.1 | 57 |
| Slices | 35 | 31 | 31 | 31 | 31 | 31 |
| cm/slices | 2.5 | 1.6 | 2.3 | 2.7 | 3.0 | 3.6 |
Figure 1.Use polymethylmethacrylate (PMMA) phantoms as patient surrogates (a) outer appearances (b) from 9th to 20th scout view of 70 kg (c) 15th CT slice of 70 kg phantom.
44 ND measurement points, and the weighting factors recommended by ICRP 103
| Organ | Measurement points | ICRP 103 | Practical evaluation |
|---|---|---|---|
| Brain | Brain | 0.01 | 0.01 |
| Salivary | Salivary | 0.01 | 0.01 |
| Thyroid | Thyroid | 0.04 | 0.04 |
| Red bone marrow | 0.12 | ||
| Clavicle vertebrae | 0.04 | ||
| Thoracic vertebra | 0.04 | ||
| Thighbone femur | 0.04 | ||
| Lung | Lung | 0.12 | 0.12 |
| Skin | Skin | 0.01 | 0.01 |
| Esophagus | Esophagus | 0.04 | 0.04 |
| Breast | Breast | 0.12 | 0.12 |
| Bone surface | 0.01 | ||
| Clavicle vertebrae | 0.025 | ||
| Thoracic vertebra | 0.025 | ||
| Thighbone | 0.025 | ||
| Rib | 0.025 | ||
| Liver | Liver | 0.04 | 0.04 |
| Colon | 0.12 | ||
| Ascending | 0.03 | ||
| Transverse | 0.03 | ||
| Descending | 0.03 | ||
| Sigmoid flexure | 0.03 | ||
| Stomach | Stomach | 0.12 | 0.12 |
| Bladder | Bladder | 0.04 | 0.04 |
| Gonads | Testes | 0.08 | 0.08 |
| Remainder | 0.12 | ||
| Lens | 0.017 | ||
| Herat | 0.017 | ||
| Pancreas | 0.017 | ||
| Spleen | 0.017 | ||
| Kidney | 0.017 | ||
| Small intestine | 0.017 | ||
| Prostate (male)/uterus (female) | 0.017 | ||
| Total | 1.00 | 1.000 | |
Figure 2.Estimate of photoneutron dose equivalent (PNDE) and skin dose per Gy (mSv/Gy) undergoing lung cancer of 15 MV IMRT treatments.
Figure 3.Secondary ND at distal edge of lung on the central axis varying distances during IMRT treatment with 15 MV (a) 90 kg, (b) 70 kg irradiation, (c) 70 kg, (d) 50 kg, (e) 30 kg, (f) 10 kg, (g) Rando phantoms.
PNDE (mSv/Gy) and estimated risk (%) of secondary cancer coming from a total 72 Gy for Rando and PMMA phantoms
| Phantom (kg) | PNDE (mSv/Gy) | Risk (%) |
|---|---|---|
| Rando | 0.67 | 2.85 |
| 10 | 0.80 | 8.35 |
| 30 | 0.74 | 7.73 |
| 50 | 0.63 | 2.68 |
| 70 | 0.61 | 2.59 |
| 90 | 0.56 | 2.38 |